19 Jul 2021 by admin in UncategorizedComments Eluminex Biosciences Exclusively Licenses FibroGen’s Biosynthetic Cornea Technology and Recombinant Collagen III Platform
15 Jul 2021 by admin in UncategorizedComments Adicet Bio Announces Formation of Scientific Advisory Board
09 Jul 2021 by admin in UncategorizedComments 日本中外制药(Chugai)与礼邦医药(Alebund)就 EOS789 开发用于高磷血症治疗达成期权/授权协议
06 Jul 2021 by admin in UncategorizedComments NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
01 Jul 2021 by admin in UncategorizedComments Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
28 Jun 2021 by admin in UncategorizedComments Tempest Closes Merger with Millendo and Completes PIPE Financing
22 Jun 2021 by admin in UncategorizedComments Tempest and Millendo Announce Stockholder Approval of Merger
